DEVELOPING EGFRXHER3 BISPECIFIC CAR-T CELLS FOR TARGETING EGFR TYROSINE KINASE INHIBITOR DRUG-TOLERANT PERSISTER CELLS

$613,125FY2025Defense Health AgencyDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators

DEVELOPING EGFRXHER3 BISPECIFIC CAR-T CELLS FOR TARGETING EGFR TYROSINE KINASE INHIBITOR DRUG-TOLERANT PERSISTER CELLS · GrantIndex